Published in Dermatol Res Pract on August 30, 2012
Hair loss and hypothalamic-pituitary-adrenocortical axis activity in captive rhesus macaques (Macaca mulatta). J Am Assoc Lab Anim Sci (2014) 0.91
Does stress increase the risk of atopic dermatitis in adolescents? results of the Korea Youth Risk Behavior Web-based Survey (KYRBWS-VI). PLoS One (2013) 0.82
Chronic stress suppresses the expression of cutaneous hypothalamic-pituitary-adrenocortical axis elements and melanogenesis. PLoS One (2014) 0.80
Norepinephrine and adenosine-5'-triphosphate synergize in inducing IL-6 production by human dermal microvascular endothelial cells. Cytokine (2013) 0.80
New approach to the understanding of keloid: psychoneuroimmune-endocrine aspects. Clin Cosmet Investig Dermatol (2015) 0.76
Sex-, Stress-, and Sympathetic Post-Ganglionic Neuron-Dependent Changes in the Expression of Pro- and Anti-Inflammatory Mediators in Rat Dural Immune Cells. Headache (2015) 0.76
Rosacea: Molecular Mechanisms and Management of a Chronic Cutaneous Inflammatory Condition. Int J Mol Sci (2016) 0.75
The Effects of Psychological Stress on Depression. Curr Neuropharmacol (2015) 0.75
The need of dermatologists, psychiatrists and psychologists joint care in psychodermatology. An Bras Dermatol (2017) 0.75
Atopic Dermatitis Studies through In Vitro Models. Front Med (Lausanne) (2017) 0.75
The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev (2000) 5.40
Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res (2002) 4.93
Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. J Immunol (1998) 4.74
Depressed lymphocyte function after bereavement. Lancet (1977) 3.45
Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis. J Immunol (2008) 3.22
Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol (2005) 3.11
Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol (2005) 3.04
Acute stress enhances while chronic stress suppresses cell-mediated immunity in vivo: a potential role for leukocyte trafficking. Brain Behav Immun (1997) 2.99
Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett (1989) 2.79
The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells. J Exp Med (2009) 2.38
Psychological stress perturbs epidermal permeability barrier homeostasis: implications for the pathogenesis of stress-associated skin disorders. Arch Dermatol (2001) 2.34
Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat Med (2001) 2.33
Human hair follicles display a functional equivalent of the hypothalamic-pituitary-adrenal axis and synthesize cortisol. FASEB J (2005) 2.23
A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today (1998) 2.19
In vivo mechanisms of cutaneous vasodilation and vasoconstriction in humans during thermoregulatory challenges. J Appl Physiol (1985) (2006) 2.09
Enhancing versus suppressive effects of stress hormones on skin immune function. Proc Natl Acad Sci U S A (1999) 2.08
Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol (2000) 2.04
Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. J Clin Invest (1997) 1.94
Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature (1993) 1.90
Effects of stress on immune cell distribution. Dynamics and hormonal mechanisms. J Immunol (1995) 1.84
Molecular dissection of psoriasis: integrating genetics and biology. J Invest Dermatol (2009) 1.79
A population-based survey of eczema prevalence in the United States. Dermatitis (2007) 1.79
Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEB J (2001) 1.74
Psychological stress downregulates epidermal antimicrobial peptide expression and increases severity of cutaneous infections in mice. J Clin Invest (2007) 1.72
Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci (1996) 1.70
Further exploring the brain-skin connection: stress worsens dermatitis via substance P-dependent neurogenic inflammation in mice. J Invest Dermatol (2007) 1.67
Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab (1993) 1.65
Catecholaminergic systems in stress: structural and molecular genetic approaches. Physiol Rev (2009) 1.63
Neuronal plasticity of the "brain-skin connection": stress-triggered up-regulation of neuropeptides in dorsal root ganglia and skin via nerve growth factor-dependent pathways. J Mol Med (Berl) (2007) 1.58
Mast cell population density, blood vessel density and histamine content in normal human skin. Br J Dermatol (1979) 1.53
The annual cost of psoriasis. J Am Acad Dermatol (1993) 1.51
Stress-induced changes in skin barrier function in healthy women. J Invest Dermatol (2001) 1.48
Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists. Trends Endocrinol Metab (2002) 1.46
Differential expression of a cutaneous corticotropin-releasing hormone system. Endocrinology (2003) 1.46
The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions. Br J Dermatol (1994) 1.45
Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: an immunocytochemical study. J Allergy Clin Immunol (1996) 1.40
Diurnal and acute stress-induced changes in distribution of peripheral blood leukocyte subpopulations. Brain Behav Immun (1994) 1.39
Role of sympathetic nerves in the vascular effects of local temperature in human forearm skin. Am J Physiol (1993) 1.35
Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci Lett (1994) 1.32
Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor. J Immunol (2005) 1.31
Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proc Assoc Am Physicians (1996) 1.30
Stressor-specific alterations in corticosterone and immune responses in mice. Brain Behav Immun (2007) 1.29
Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system. Prog Neurobiol (1993) 1.27
Mechanisms by which psychologic stress alters cutaneous permeability barrier homeostasis and stratum corneum integrity. J Invest Dermatol (2005) 1.26
Depression, cortisol, and suppressed cell-mediated immunity in metastatic breast cancer. Brain Behav Immun (2009) 1.26
Melatonin in the skin: synthesis, metabolism and functions. Trends Endocrinol Metab (2007) 1.20
Glucocorticoid blockade reverses psychological stress-induced abnormalities in epidermal structure and function. Am J Physiol Regul Integr Comp Physiol (2006) 1.19
Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin, and substance P: A link to neurogenic skin disorders. Brain Behav Immun (1999) 1.18
Acute stress enhances while chronic stress suppresses skin immunity. The role of stress hormones and leukocyte trafficking. Ann N Y Acad Sci (2000) 1.13
Altered responsiveness of the hypothalamus-pituitary-adrenal axis and the sympathetic adrenomedullary system to stress in patients with atopic dermatitis. J Clin Endocrinol Metab (2002) 1.13
Distribution of mast cells in human dermis: development of a mapping technique. Br J Dermatol (1979) 1.11
Interleukin-6. The major regulator of acute-phase protein synthesis in man and rat. Ann N Y Acad Sci (1989) 1.10
Calcitonin gene-related peptide biases Langerhans cells toward Th2-type immunity. J Immunol (2008) 1.09
Anxiety in allergy and atopic dermatitis. Curr Opin Allergy Clin Immunol (2006) 1.07
Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol (2002) 1.06
Catecholamines inhibit the antigen-presenting capability of epidermal Langerhans cells. J Immunol (2002) 1.04
Langerhans cells: critical regulators of skin immunity? Immunol Cell Biol (2010) 1.03
Coexpression of cholinergic and noradrenergic phenotypes in human and nonhuman autonomic nervous system. J Comp Neurol (2005) 1.03
Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast cells. J Invest Dermatol (2011) 1.03
Psychodermatology: a guide to understanding common psychocutaneous disorders. Prim Care Companion J Clin Psychiatry (2007) 1.02
The skin produces urocortin. J Clin Endocrinol Metab (2000) 1.01
Mast cells as sources of tissue histamine. J Exp Med (1955) 1.00
The stratum corneum barrier: the final frontier. J Nutr (2004) 1.00
Psychological influences in psoriasis. Clin Exp Dermatol (2001) 0.99
In situ expression of corticotropin-releasing hormone (CRH) and proopiomelanocortin (POMC) genes in human skin. FASEB J (2001) 0.98
Hair-cycle-associated remodeling of the peptidergic innervation of murine skin, and hair growth modulation by neuropeptides. J Invest Dermatol (2001) 0.97
Hypothalamic-pituitary cytokine network. Endocrinology (2003) 0.96
Liquid chromatography-mass spectrometry detection of corticotropin-releasing hormone and proopiomelanocortin-derived peptides in human skin. J Clin Endocrinol Metab (2000) 0.96
Morphine directly modulates the release of stimulated corticotrophin-releasing factor-41 from rat hypothalamus in vitro. Endocrinology (1989) 0.96
Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression. Clin Exp Immunol (1992) 0.96
Interleukin (IL)-6, but not IL-1, induction in the brain downstream of cyclooxygenase-2 is essential for the induction of febrile response against peripheral IL-1alpha. Endocrinology (2004) 0.95
Biofeedback, cognitive-behavioral methods, and hypnosis in dermatology: is it all in your mind? Dermatol Ther (2003) 0.95
Corticosteroids but not pimecrolimus affect viability, maturation and immune function of murine epidermal Langerhans cells. J Invest Dermatol (2004) 0.94
Immobilization-induced and crowded environment-induced stress delay barrier recovery in murine skin. Br J Dermatol (1998) 0.94
Effect of stress on skin transplantation immunity in mice. Science (1960) 0.94
Effect of stress on atopic dermatitis: investigation in patients after the great hanshin earthquake. J Allergy Clin Immunol (1999) 0.94
The effects of acute social stress on epidermal Langerhans' cell frequency and expression of cutaneous neuropeptides. J Invest Dermatol (2007) 0.92
Stress as an influencing factor in psoriasis. Skin Therapy Lett (2011) 0.92
Prolactin and its receptor are expressed in murine hair follicle epithelium, show hair cycle-dependent expression, and induce catagen. Am J Pathol (2003) 0.92
Effects of serotonergic agonists and antagonists on corticotropin-releasing hormone secretion by explanted rat hypothalami. Peptides (1989) 0.91
Inflammatory cytokines: putative regulators of neuronal and neuro-endocrine function. Brain Res Brain Res Rev (1998) 0.91
Enhanced dendritic cell antigen uptake via alpha2 adrenoceptor-mediated PI3K activation following brief exposure to noradrenaline. J Immunol (2010) 0.90
Stress-induced immunomodulation is altered in patients with atopic dermatitis. J Neuroimmunol (2002) 0.90
Prolactin--a novel neuroendocrine regulator of human keratin expression in situ. FASEB J (2010) 0.89
Hypnosis in dermatology. Arch Dermatol (2000) 0.89
Psychoneuroimmunology. Dermatol Ther (2008) 0.89
Targeting cognitive-behaviour therapy to patients' implicit model of psoriasis: results from a patient preference controlled trial. Br J Clin Psychol (2004) 0.88
Psychodermatological disorders: recognition and treatment. Int J Dermatol (2011) 0.88
Psychiatric disorders in patients attending a dermatology outpatient clinic. Dermatology (1998) 0.88
Association of cutaneous mast cells and sensory nerves with psychic stress in psoriasis. Psychother Psychosom (1993) 0.88
Altered distribution of leukocyte subsets and cytokine production in response to acute psychosocial stress in patients with psoriasis vulgaris. Brain Behav Immun (2006) 0.85
C57BL/6 mice are resistant to acute restraint modulation of cutaneous hypersensitivity. Toxicol Sci (2001) 0.85
Neuroimmune mechanisms in patients with atopic dermatitis during chronic stress. J Eur Acad Dermatol Venereol (2008) 0.84
Neuroendocrine regulation of skin dendritic cells. Ann N Y Acad Sci (2006) 0.83
Transmitter release in skin and muscle blood vessels during sympathetic stimulation. Am J Physiol (1967) 0.83
Endocrine stress responses in TH1-mediated chronic inflammatory skin disease (psoriasis vulgaris)--do they parallel stress-induced endocrine changes in TH2-mediated inflammatory dermatoses (atopic dermatitis)? Psychoneuroendocrinology (2005) 0.83
Neuro-mediators as predictors of paediatric atopic dermatitis. Clin Exp Allergy (2008) 0.83
Specific up-regulation of CRH or AVP secretion by acetylcholine or lipopolysaccharide in inflammatory susceptible Lewis rat fetal hypothalamic cells. J Neuroimmunol (2002) 0.82
Prolactin: an emerging force along the cutaneous-endocrine axis. Trends Endocrinol Metab (2010) 0.82
Generation and function of reactive oxygen species in dendritic cells during antigen presentation. J Immunol (2003) 1.97
Do atypical antipsychotics effectively treat co-occurring bipolar disorder and stimulant dependence? A randomized, double-blind trial. J Clin Psychiatry (2008) 1.70
Delayed-onset nodules secondary to a smooth cohesive 20 mg/mL hyaluronic acid filler: cause and management. Dermatol Surg (2015) 1.47
Involvement of hyaluronan in epidermal Langerhans cell maturation and migration in vivo. J Dermatol Sci (2003) 0.95
Prevalence and risk of homelessness among US veterans. Prev Chronic Dis (2012) 0.95
Hair follicles serve as local reservoirs of skin mast cell precursors. Blood (2003) 0.95
Polymeric nanoparticles for sustained down-regulation of annexin A2 inhibit prostate tumor growth. J Nanosci Nanotechnol (2009) 0.95
Keratinocyte ATP release assay for testing skin-irritating potentials of structurally diverse chemicals. J Invest Dermatol (2003) 0.89
Hyaluronan synthesis is required for IL-2-mediated T cell proliferation. J Immunol (2007) 0.89
Fluorescence detection of hyaluronidase. J Photochem Photobiol B (2011) 0.89
The Joint Admission Medical Program: a statewide approach to expanding medical education and career opportunities for disadvantaged students. Acad Med (2009) 0.88
Functional roles of hyaluronan in B16-F10 melanoma growth and experimental metastasis in mice. Mol Cancer Ther (2003) 0.88
Development of a fluorescent substrate to measure hyaluronidase activity. Anal Biochem (2008) 0.86
Tumor microenvironment modulates hyaluronan expression: the lactate effect. J Invest Dermatol (2006) 0.86
Hyperbaric oxygen treatment attenuates the pro-inflammatory and immune responses in apolipoprotein E knockout mice. Clin Immunol (2008) 0.83
Lifetime-based sensing of the hyaluronidase using fluorescein labeled hyaluronic acid. J Photochem Photobiol B (2011) 0.83
Inducible macropinocytosis of hyaluronan in B16-F10 melanoma cells. Matrix Biol (2010) 0.82
Development of a hyaluronan bioconjugate for the topical treatment of melanoma. J Dermatol Sci (2009) 0.81
Pep-1 as a novel probe for the in situ detection of hyaluronan. J Histochem Cytochem (2005) 0.81
Allele-specific effects of ecSOD on asbestos-induced fibroproliferative lung disease in mice. Free Radic Biol Med (2011) 0.79
Langerhans cells in CD44-deficient mice emigrate from the epidermis but fail to reach the lymph nodes after hapten application. J Invest Dermatol (2004) 0.77
Development of a hyaluronan targeted contrast reagent for the demarcation of melanoma margins in vivo. J Invest Dermatol (2007) 0.75
A motor vehicle collision involving a veteran: a teaching case from the joining forces teaching curriculum for medical students. Md Med (2012) 0.75
What the Joint Admission Medical Program (JAMP) can do for Texas physicians; what Texas physicians can do for JAMP. Tex Med (2012) 0.75